+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Epigenetics Market by Product (Enzymes, Instruments & Accessories, Reagents & Kits), Technique (Mass Spectrometry, Next-Generation Sequencing, Polymerase Chain Reaction & quantitative Polymerase Chain Reaction), Methods, Application, End User - Forecast 2023-2030- Product Image
Global Epigenetics Market by Product (Enzymes, Instruments & Accessories, Reagents & Kits), Technique (Mass Spectrometry, Next-Generation Sequencing, Polymerase Chain Reaction & quantitative Polymerase Chain Reaction), Methods, Application, End User - Forecast 2023-2030- Product Image
Sale

Global Epigenetics Market by Product (Enzymes, Instruments & Accessories, Reagents & Kits), Technique (Mass Spectrometry, Next-Generation Sequencing, Polymerase Chain Reaction & quantitative Polymerase Chain Reaction), Methods, Application, End User - Forecast 2023-2030

  • PDF Icon

    Report

  • 185 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5665871
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Epigenetics Market size was estimated at USD 3.37 billion in 2022, USD 3.71 billion in 2023, and is expected to grow at a CAGR of 10.75% to reach USD 7.63 billion by 2030.

Epigenetics refers to the analysis of heritable phenotype modifications that do not involve alterations in the DNA sequence. It examines the chemical modifications that occur on DNA and histone proteins, which can affect gene expression without changing the underlying genetic code. These epigenetic changes can be influenced by several factors, including age, environment, and disease state, and they are reversible mechanisms passed down to subsequent generations. Epigenetics provides an additional layer of complexity to the regulation of gene expression, and it has significant implications for our understanding of genetics, development, and inheritance. Applications of epigenetics span from biomedical research to therapeutic interventions. In research, epigenetics offers insights into developmental biology and the etiology of diseases. Clinically, it has implications in cancer treatment, metabolic disorders, and personalized medicine. The primary end-users include academic & research institutes, pharmaceutical & biotech companies, and diagnostic centers. The need for epigenetics is increasing due to substantial growth in the prevalence of chronic and genetic disorders worldwide, favorable governmental initiatives and investments in drug discovery and development, and a growing inclination toward personalized medicines. However, the market faces certain challenges, including the high cost of developing epigenetics technologies, lack of awareness, and limited application of epigenetics, hindering the adoption of epigenetics. Ongoing research and development activities for the advancement of epigenetics and expanding the application of epigenetics in non-oncology fields present potential opportunities for the development of epigenetics.

Regional Insights

The epigenetics market in North America has exhibited substantial growth, primarily driven by the United States, attributed to heavy investments in research and development, the robust presence of pharmaceutical and biotechnology companies, and a high incidence rate of chronic diseases such as cancer. In South America, the adoption of epigenetics is in the nascent stage and has a potential for development due to the increasing prevalence of genetic disorders and cancers, and Brazil supports the development of epigenetics with an evolving healthcare sector and growing public awareness about advanced treatments. The APAC region is undergoing a rapid transition in the epigenetics sector due to emerging economies such as China, Japan, and India. China has witnessed a surge in patent filings, indicating strong governmental and private interest in epigenetics. The Japanese government encourages precision medicine, resulting in increased funding for epigenetic research programs. India's participation in epigenetic research is expanding, with an increasing number of collaborations and studies. Europe's epigenetics market is robust, led by countries such as Germany, the UK, and France. Extensive research activities, well-established healthcare systems, and growing investments from the private and public sectors propel the regional development. Additionally, active collaborations between key players and academic institutions support the development of advanced epigenetic therapies. The Middle East region is experiencing gradual progress in epigenetics due to the rising prevalence of conditions such as cancer and the expansion of healthcare infrastructure. The interest in personalized medicine is steadily gaining traction, influencing purchasing patterns. In Africa, the development of epigenetics is in the early stages, with limited research facilities. However, there is potential for expansion with increasing international collaboration in healthcare research.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Epigenetics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Epigenetics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Epigenetics Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Abnova Corporation, Active Motif, Inc., Agilent Technologies, Inc., AstraZeneca PLC, Bayer AG, Bio-Rad Laboratories, Inc., BioCat GmbH by AddLife AB, Bioneer Corporation, BPS Bioscience, Inc., Bristol-Myers Squibb Company, Cambridge Epigenetix Ltd., Chroma Medicine, Inc., Creative Biogene, Creative Diagnostics, Cusabio Technology LLC, Diagenode S.A. by Hologic, Inc., Elysium Health, Inc., EpiCypher, Inc., Epigenic Therapeutics, EpiGentek Group Inc., Eurofins Scientific SE, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Fios Genomics Ltd., FOXO Technologies Inc., GenomeScan, GenScript Biotech Corporation, Gilead Sciences, Inc., Illumina, Inc., Integrated DNA Technologies, Inc. by Danaher Corporation, Ipsen, Lonza Group Ltd., Merck KGaA, MorphoSys AG, New England Biolabs, Inc., Novogene Co, Ltd., Omega Therapeutics, Inc., Pacific Biosciences of California, Inc, PerkinElmer, Inc., Promega Corporation, ProteoGenix SAS, Qiagen N.V., Sound Agriculture Company, STORM Therapeutics LTD, Takara Holdings Inc., Thermo Fisher Scientific Inc., Twist Bioscience Corporation, Watchmaker Genomics, Inc., Zenith Epigenetics Ltd., and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Epigenetics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Enzymes
      • DNA-Modifying Enzymes
      • Protein-Modifying Enzymes
    • Instruments & Accessories
    • Reagents & Kits
      • 5-hmC & 5-mC Analysis Kit
      • Antibodies
      • Bisulfite Conversion Kits
      • ChiP-seq Kits
      • Histones
      • Whole Genome Amplification Kits
    • Service
    • Software
  • Technique
    • Mass Spectrometry
    • Next-Generation Sequencing
    • Polymerase Chain Reaction & quantitative Polymerase Chain Reaction
    • Sonication
  • Methods
    • DNA Methylation
    • Histone Modifications
  • Application
    • Cardiovascular Diseases
    • Developmental Biology
    • Immunology
    • Metabolic Diseases
    • Oncology
  • End User
    • Academic & Research Institutes
    • Contract Research Organizations
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Epigenetics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Epigenetics Market?
  3. What are the technology trends and regulatory frameworks in the Epigenetics Market?
  4. What is the market share of the leading vendors in the Epigenetics Market?
  5. Which modes and strategic moves are suitable for entering the Epigenetics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Epigenetics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Significant growth in the prevalence of chronic and genetic disorders worldwide
5.1.1.2. Favorable governmental initiatives and investments in drug discovery and development
5.1.1.3. Growing inclination toward personalized medicines
5.1.2. Restraints
5.1.2.1. High cost of development of epigenetics technologies
5.1.3. Opportunities
5.1.3.1. Ongoing research and development activities for the advancement of epigenetics
5.1.3.2. Expanding the application of epigenetics in non-oncology fields
5.1.4. Challenges
5.1.4.1. Lack of awareness and limited application of epigenetics
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing usage of reagents & kits for epigenetic research
5.2.2. Technique: Expanding adoption of next-generation sequencing for genome-wide methylation profiling
5.2.3. Methods: Rising utilization of DNA methylation for X-chromosome inactivation
5.2.4. Application: Increasing application of epigenetic tools in oncology
5.2.5. End-User: Growing need for epigenetic tools from academic & research institutes
5.3. Market Trend Analysis
5.3.1. Continuous epigenetics research for clinical and agricultural applications and technological advancements with a presence of major players in the Americas region
5.3.2. Increasing research and development activities coupled with growing geriatric population in the APAC region
5.3.3. Advanced healthcare infrastructure and strong epigenetics research activities associated with environment and agricultural applications in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Epigenetics Market, by Product
6.1. Introduction
6.2. Enzymes
6.3.1. DNA-Modifying Enzymes
6.3.2. Protein-Modifying Enzymes
6.3. Instruments & Accessories
6.4. Reagents & Kits
6.5.1. 5-hmC & 5-mC Analysis Kit
6.5.2. Antibodies
6.5.3. Bisulfite Conversion Kits
6.5.4. ChiP-seq Kits
6.5.5. Histones
6.5.6. Whole Genome Amplification Kits
6.5. Service
6.6. Software
7. Epigenetics Market, by Technique
7.1. Introduction
7.2. Mass Spectrometry
7.3. Next-Generation Sequencing
7.4. Polymerase Chain Reaction & quantitative Polymerase Chain Reaction
7.5. Sonication
8. Epigenetics Market, by Methods
8.1. Introduction
8.2. DNA Methylation
8.3. Histone Modifications
9. Epigenetics Market, by Application
9.1. Introduction
9.2. Cardiovascular Diseases
9.3. Developmental Biology
9.4. Immunology
9.5. Metabolic Diseases
9.6. Oncology
10. Epigenetics Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Contract Research Organizations
10.4. Pharmaceutical & Biotechnology Companies
11. Americas Epigenetics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Epigenetics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Epigenetics Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. Merger & Acquisition
14.3.1.1. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
14.3.1.2. Ipsen to Acquire Epizyme, Expanding its Portfolio in Oncology
14.3.2. Agreement, Collaboration, & Partnership
14.3.2.1. Zenith and Cencora Partner to Expedite ZEN-3694 Programme
14.3.2.2. FOXO, DataRobot Partner for AI-Based Epigenetic Biomarker Research
14.3.2.3. Zymo Research and Opentrons Partner to Automate Novel Cell-Free DNA Isolation Chemistry
14.3.2.4. Zenith Epigenetics Announces Start of Several National Cancer Institute (NCI)-Sponsored Oncology Clinical Trials
14.3.3. New Product Launch & Enhancement
14.3.3.1. AstraZeneca Advances its Pipeline and Highlights Progress in Immuno-Oncology, ADCs, Cell Therapy and Epigenetics At AACR
14.3.3.2. Biomodal Releases Genetics And Epigenetics Solution
14.3.4. Investment & Funding
14.3.4.1. MSU biochemist Receives USD 2.8 million NIH Grant For Epigenetic Research on Autism Spectrum Disorder
14.3.4.2. Chroma Medicine Raises Stakes in Epigenetic Editing
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Abcam PLC
15.1.2. Abnova Corporation
15.1.3. Active Motif, Inc.
15.1.4. Agilent Technologies, Inc.
15.1.5. AstraZeneca PLC
15.1.6. Bayer AG
15.1.7. Bio-Rad Laboratories, Inc.
15.1.8. BioCat GmbH by AddLife AB
15.1.9. Bioneer Corporation
15.1.10. BPS Bioscience, Inc.
15.1.11. Bristol-Myers Squibb Company
15.1.12. Cambridge Epigenetix Ltd.
15.1.13. Chroma Medicine, Inc.
15.1.14. Creative Biogene
15.1.15. Creative Diagnostics
15.1.16. Cusabio Technology LLC
15.1.17. Diagenode S.A. by Hologic, Inc.
15.1.18. Elysium Health, Inc.
15.1.19. EpiCypher, Inc.
15.1.20. Epigenic Therapeutics
15.1.21. EpiGentek Group Inc.
15.1.22. Eurofins Scientific SE
15.1.23. Exact Sciences Corporation
15.1.24. F. Hoffmann-La Roche Ltd.
15.1.25. Fios Genomics Ltd.
15.1.26. FOXO Technologies Inc.
15.1.27. GenomeScan
15.1.28. GenScript Biotech Corporation
15.1.29. Gilead Sciences, Inc.
15.1.30. Illumina, Inc.
15.1.31. Integrated DNA Technologies, Inc. by Danaher Corporation
15.1.32. Ipsen
15.1.33. Lonza Group Ltd.
15.1.34. Merck KGaA
15.1.35. MorphoSys AG
15.1.36. New England Biolabs, Inc.
15.1.37. Novogene Co, Ltd.
15.1.38. Omega Therapeutics, Inc.
15.1.39. Pacific Biosciences of California, Inc
15.1.40. PerkinElmer, Inc.
15.1.41. Promega Corporation
15.1.42. ProteoGenix SAS
15.1.43. Qiagen N.V.
15.1.44. Sound Agriculture Company
15.1.45. STORM Therapeutics LTD
15.1.46. Takara Holdings Inc.
15.1.47. Thermo Fisher Scientific Inc.
15.1.48. Twist Bioscience Corporation
15.1.49. Watchmaker Genomics, Inc.
15.1.50. Zenith Epigenetics Ltd.
15.1.51. Zymo Research Corporation
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. EPIGENETICS MARKET RESEARCH PROCESS
FIGURE 2. EPIGENETICS MARKET SIZE, 2022 VS 2030
FIGURE 3. EPIGENETICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. EPIGENETICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. EPIGENETICS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. EPIGENETICS MARKET DYNAMICS
FIGURE 7. EPIGENETICS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. EPIGENETICS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2022 VS 2030 (%)
FIGURE 10. EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. EPIGENETICS MARKET SIZE, BY METHODS, 2022 VS 2030 (%)
FIGURE 12. EPIGENETICS MARKET SIZE, BY METHODS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. EPIGENETICS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 14. EPIGENETICS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. EPIGENETICS MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 16. EPIGENETICS MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 20. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. EPIGENETICS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 26. EPIGENETICS MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. EPIGENETICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. EPIGENETICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. EPIGENETICS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 8. EPIGENETICS MARKET SIZE, BY DNA-MODIFYING ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. EPIGENETICS MARKET SIZE, BY PROTEIN-MODIFYING ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. EPIGENETICS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 13. EPIGENETICS MARKET SIZE, BY 5-HMC & 5-MC ANALYSIS KIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. EPIGENETICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. EPIGENETICS MARKET SIZE, BY BISULFITE CONVERSION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. EPIGENETICS MARKET SIZE, BY CHIP-SEQ KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. EPIGENETICS MARKET SIZE, BY HISTONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. EPIGENETICS MARKET SIZE, BY WHOLE GENOME AMPLIFICATION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. EPIGENETICS MARKET SIZE, BY SERVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. EPIGENETICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 22. EPIGENETICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. EPIGENETICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. EPIGENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION & QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. EPIGENETICS MARKET SIZE, BY SONICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 27. EPIGENETICS MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. EPIGENETICS MARKET SIZE, BY HISTONE MODIFICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. EPIGENETICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. EPIGENETICS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. EPIGENETICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. EPIGENETICS MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. EPIGENETICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. EPIGENETICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. EPIGENETICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. EPIGENETICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. CANADA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. CANADA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 63. CANADA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 64. CANADA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 65. CANADA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 66. CANADA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. CANADA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. MEXICO EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. MEXICO EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 70. MEXICO EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 71. MEXICO EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 72. MEXICO EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 73. MEXICO EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. MEXICO EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 95. AUSTRALIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 96. AUSTRALIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. AUSTRALIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. CHINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. CHINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 100. CHINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 101. CHINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 102. CHINA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 103. CHINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. CHINA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. INDIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. INDIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 107. INDIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 108. INDIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 109. INDIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 110. INDIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. INDIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 115. INDONESIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 116. INDONESIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 117. INDONESIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. INDONESIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. JAPAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. JAPAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 121. JAPAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 122. JAPAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 123. JAPAN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 124. JAPAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. JAPAN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 129. MALAYSIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 130. MALAYSIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 131. MALAYSIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. MALAYSIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 136. PHILIPPINES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 137. PHILIPPINES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 138. PHILIPPINES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. PHILIPPINES EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 144. SINGAPORE EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 145. SINGAPORE EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. SINGAPORE EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 151. SOUTH KOREA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 152. SOUTH KOREA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. SOUTH KOREA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 157. TAIWAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 158. TAIWAN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 159. TAIWAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. TAIWAN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. THAILAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. THAILAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 163. THAILAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 164. THAILAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 165. THAILAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 166. THAILAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. THAILAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 171. VIETNAM EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 172. VIETNAM EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 173. VIETNAM EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. VIETNAM EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 183. DENMARK EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. DENMARK EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 185. DENMARK EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 186. DENMARK EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 187. DENMARK EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 188. DENMARK EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. DENMARK EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. EGYPT EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. EGYPT EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 192. EGYPT EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 193. EGYPT EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 194. EGYPT EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 195. EGYPT EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. EGYPT EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. FINLAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. FINLAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 199. FINLAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 200. FINLAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 201. FINLAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 202. FINLAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. FINLAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. FRANCE EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. FRANCE EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 206. FRANCE EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 207. FRANCE EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 208. FRANCE EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 209. FRANCE EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. FRANCE EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. GERMANY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 212. GERMANY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 213. GERMANY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 214. GERMANY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 215. GERMANY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 216. GERMANY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. GERMANY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 221. ISRAEL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 222. ISRAEL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 223. ISRAEL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. ISRAEL EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. ITALY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. ITALY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 227. ITALY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 228. ITALY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 229. ITALY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 230. ITALY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. ITALY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. NORWAY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 247. NORWAY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 248. NORWAY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 249. NORWAY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 250. NORWAY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 251. NORWAY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. NORWAY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. POLAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 254. POLAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 255. POLAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 256. POLAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 257. POLAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 258. POLAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. POLAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. QATAR EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 261. QATAR EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 262. QATAR EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 263. QATAR EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 264. QATAR EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 265. QATAR EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. QATAR EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 272. RUSSIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. RUSSIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. SPAIN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 289. SPAIN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 290. SPAIN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 291. SPAIN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 292. SPAIN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 293. SPAIN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. SPAIN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 305. SWITZERLAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 306. SWITZERLAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 307. SWITZERLAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 308. SWITZERLAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. TURKEY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 310. TURKEY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 311. TURKEY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 312. TURKEY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 313. TURKEY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 314. TURKEY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. TURKEY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 324. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 326. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 328. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 330. EPIGENETICS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 331. EPIGENETICS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 332. EPIGENETICS MARKET LICENSE & PRICING

Companies Mentioned

  • Abcam PLC
  • Abnova Corporation
  • Active Motif, Inc.
  • Agilent Technologies, Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Bio-Rad Laboratories, Inc.
  • BioCat GmbH by AddLife AB
  • Bioneer Corporation
  • BPS Bioscience, Inc.
  • Bristol-Myers Squibb Company
  • Cambridge Epigenetix Ltd.
  • Chroma Medicine, Inc.
  • Creative Biogene
  • Creative Diagnostics
  • Cusabio Technology LLC
  • Diagenode S.A. by Hologic, Inc.
  • Elysium Health, Inc.
  • EpiCypher, Inc.
  • Epigenic Therapeutics
  • EpiGentek Group Inc.
  • Eurofins Scientific SE
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd.
  • Fios Genomics Ltd.
  • FOXO Technologies Inc.
  • GenomeScan
  • GenScript Biotech Corporation
  • Gilead Sciences, Inc.
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc. by Danaher Corporation
  • Ipsen
  • Lonza Group Ltd.
  • Merck KGaA
  • MorphoSys AG
  • New England Biolabs, Inc.
  • Novogene Co, Ltd.
  • Omega Therapeutics, Inc.
  • Pacific Biosciences of California, Inc
  • PerkinElmer, Inc.
  • Promega Corporation
  • ProteoGenix SAS
  • Qiagen N.V.
  • Sound Agriculture Company
  • STORM Therapeutics LTD
  • Takara Holdings Inc.
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
  • Watchmaker Genomics, Inc.
  • Zenith Epigenetics Ltd.
  • Zymo Research Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedMarch 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 3.71 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.63 Billion
Compound Annual Growth Rate10.7%
Regions CoveredGlobal
No. of Companies Mentioned51

Related Topics

Related Reports

Epigenetics Market Size, Share & Trends Analysis Report By Product (Reagents, Kits), By Application (Oncology, Non-oncology), By Technology (MicroRNA Modification, Chromatin Structures), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Epigenetics Market Size, Share & Trends Analysis Report By Product (Reagents, Kits), By Application (Oncology, Non-oncology), By Technology (MicroRNA Modification, Chromatin Structures), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 150 Pages
  • Global
From
Epigenetics Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Kits, Instruments, Enzymes, Services), By Application (Oncology, Non-oncology), By Technology, By Region, And Segment Forecasts, 2023-2030 - Product Image

Epigenetics Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Kits, Instruments, Enzymes, Services), By Application (Oncology, Non-oncology), By Technology, By Region, And Segment Forecasts, 2023-2030

  • Report
  • 150 Pages
  • Global
From
Global Epigenetics Market by Product & Service (Enzymes (DNA-modifying Enzymes), Kits & Reagents (Antibodies), Instrument, Software), Method (DNA Methylation), Technique (NGS, PCR, Mass Spectrometry), Application (Oncology, Immunology), and Region - Forecast to 2028 - Product Image

Global Epigenetics Market by Product & Service (Enzymes (DNA-modifying Enzymes), Kits & Reagents (Antibodies), Instrument, Software), Method (DNA Methylation), Technique (NGS, PCR, Mass Spectrometry), Application (Oncology, Immunology), and Region - Forecast to 2028

  • Report
  • 353 Pages
  • Global
From
Epigenetics Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Image

Epigenetics Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • 146 Pages
  • Global
From
Epigenetics Global Market Report 2024 - Product Image

Epigenetics Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.